
Passionate cardiologist, special interest in cardiac imaging #cardiology #kardiologie #CardioTweeter #echocardiography
Nicosia, Cyprus
Joined March 2022
- Tweets66
- Following158
- Followers57
- Likes212
DrFayApostolou retweeted
New Research: Case report: Aborted sudden cardiac death as a first presentation of severe mitral annulus disjunction—a case series and review of the literature: Mitral annulus disjunction (MAD) is defined as a systolic displacement… #cardiovascular frontiersin.org/articles/10.…
DrFayApostolou retweeted
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis. Read more in #EHJ
@escardio @ESC_Journals #CardioTwitter
academic.oup.com/eurheartj/a…
DrFayApostolou retweeted
Hypertrophic cardiomyopathy, ♀️ vs ♂️
✅later recognition of oHCM in women
✅less active pharmacological management than in males
➡️female survival ⬇️in oHCM with ⬆️mortality particularly in #HF and myocardial infarctions
@escardio @EAPCPresident @MichaelPapadak2 @m_piepoli
DrFayApostolou retweeted
Spread the word @AthanasiosKorda!!! Catheter ablation ⚡️is now the first line treatment of symptomatic idiopathic PVCs/VT originated from the RVOT or left fascicles!! 🔬🫀#ESCGuidelines #ESCCongress #MedTwitter #Cardiology @ESCardioNews @escardio – at Koufonisi, Greece
DrFayApostolou retweeted
Just released during #ESCCongress
#ESCGuidelines for patients on:
▶️#HeartFailure
▶️#Prevention
escardio.org/Guidelines/guid…
Thank you to our wonderful #ESCPatientForum members for their involvement and dedication 🤗
@Mary_Galb @Rhythmisit @AVerstrael
DrFayApostolou retweeted
New #ERS guidelines on pulmonary hypertension #ESCCongress
@susannaprice @CVandenbriele @umityasarsinan1 @saskavaska @ASionis @rafavidalperez @SaDeRosa78 @HanCardiomd @dr_maghraby @BenediktSchrage @EduPOCUS @NMerke @KemalogluOz
DrFayApostolou retweeted
#ESCCongress
🚩The 2022 ESC Guidelines on Cardiovascular Assessment and Management of Patients Undergoing Non-cardiac Surgery @escardio
🌟What is New in the 3️⃣ important elements👇
✅Clinical risk evaluation
✅Pre-operative assessment tools
✅General risk reduction strategies
DrFayApostolou retweeted
Must read: new 2022 ventricular #arrhythmias and #SuddenCardiacDeath guidelines academic.oup.com/eurheartj/a…
#ESCGuidelines #ESCCongress #cardiotwitter #medtwitter
DrFayApostolou retweeted
In this study , mild paravalvular regurgitation (PVR) has a significant impact on five-year mortality after TAVI. The risk of PVR should be taken into account for decision making between TAVI and SAVR, particularly in younger patients. #EAPCI ow.ly/B35O50JghiR
DrFayApostolou retweeted
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome
heart.bmj.com/content/early/…
DrFayApostolou retweeted
New Research: Unravelling the Difference Between Men and Women in Post-CABG Survival: Objectives
Women have a worse prognosis after coronary artery bypass grafting (CABG) surgery compared to men. We sought to quantify to what extent this… frontiersin.org/articles/10.… #cardiovascular
DrFayApostolou retweeted
⚠️New 👉SGLT2i in Acute Heart Failure: a Review of the Available Evidence and Practical Guidance on Clinical Use
@Hermi_Morillas @JuliaSellerm @Ed_Alania @AinhoaLarumbe @riberasalud @yulnunezvill. @secardiologia @emigalcera1
DrFayApostolou retweeted
"Coronary flow reserve and coronary flow capacity at a time of shifting paradigms of ischaemic heart disease". An Editorial from Escaned J, et al. #EIJBestOf ow.ly/9S6850IFQT3
DrFayApostolou retweeted
Fractional flow reserve is non-inferior and leads to fewer stents implanted compared with intravascular ultrasound.
Listen to Prof. @DFCapodanno's insights on the FLAVOUR trial from #ACC22
Access full ESC TV reports from ACC.22 bit.ly/3NV1KrE
#cardiotwitter #medtwitter
DrFayApostolou retweeted
#EHRA2022 VTs in laminopathies by @micaela_ebert
▶️ Arrhythmic risk depends on etiology
▶️ Multple VT morphologies
⬆️ Anteroseptal
@rbcasado @Kasia_Rajpold @DavidDuncker @RodrigueGarcia4 @Dominik_Linz @EmmaSvennberg @CarolRemme @Moscoso_Costa
#EHRA2022TogetherAgain #EPeeps
DrFayApostolou retweeted
ICYMI: "The lifetime management of these patients requires an understanding of bioprosthetic valve durability and failure, both of transcatheter valves and surgical prostheses.” @HMethodistCV @hmdhvc @ACCinTouch #ACC22 #CardioTwitter healio.com/news/cardiac-vasc…






































